Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
CN Stock MarketDetailed Quotes
Nanjing Pharmaceutical Group (600713)
- 5.53
- -0.17-2.98%
Market Closed Apr 24 15:00 CST
7.24BMarket Cap11.59P/E (TTM)
5.65High5.50Low291.94KlotVolume5.61Open5.70Prev Close161.83MTurnover2.26%Turnover Ratio11.59P/E (Static)1.31BShares6.6552wk High1.01P/B7.13BFloat Cap4.8152wk Low6.27Limit Up1.29BShs Float19.45Historical High5.13Limit Down2.63%Range %-0.44Historical Low0.17Dividend TTM5.54Avg Price176.39KlotAsk3.07%Div Yield TTM100Lot Size107.92KlotBid
Nanjing Pharmaceutical Group (600713) Balance Sheet
All
YOY
| (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -33.17%3.05B | 45.98%1.69B | -6.34%2.31B | 40.74%2.31B | 92.39%4.56B | -1.97%1.16B | 22.63%2.46B | 18.05%1.64B | 1.91%2.37B | -20.98%1.18B |
| Transactional financial assets | --215.28M | --290.51M | --82.03M | --340.35M | ---- | ---- | ---- | ---- | ---- | ---- |
| Notes receivable and accounts receivable | 3.67%13.04B | -5.91%16.84B | 10.74%17.34B | -2.60%17.49B | -10.75%12.58B | -8.37%17.89B | -16.44%15.65B | -2.37%17.96B | -15.78%14.1B | 11.36%19.53B |
| -Notes receivable | -65.51%197.3M | -64.59%332.48M | -63.79%387.14M | -47.66%1.08B | -75.72%572.09M | -64.98%938.92M | -63.27%1.07B | -7.67%2.06B | -2.14%2.36B | -7.74%2.68B |
| -Accounts receivable | 6.96%12.85B | -2.66%16.5B | 16.21%16.95B | 3.25%16.42B | 2.29%12.01B | 0.64%16.95B | -7.83%14.58B | -1.64%15.9B | -18.07%11.74B | 15.15%16.85B |
| Other receivables (including interest and dividends) | 0.75%818.21M | 31.71%947.8M | 10.66%935.03M | 16.73%810.85M | 38.14%812.09M | 8.27%719.61M | 35.57%844.94M | 13.92%694.64M | 18.02%587.89M | 34.19%664.66M |
| -Other receivable | 0.75%818.21M | ---- | 10.66%935.03M | ---- | 38.14%812.09M | ---- | 35.57%844.94M | ---- | 18.02%587.89M | ---- |
| Advance payment | 9.61%975.01M | 18.97%1.05B | -5.49%969.14M | -9.93%991.83M | -0.49%889.51M | 20.34%882.64M | 19.85%1.03B | 16.83%1.1B | -22.40%893.91M | -7.24%733.45M |
| Inventories | 9.83%6.9B | 9.63%6.61B | 4.19%6.16B | 6.89%6.28B | 8.42%6.29B | 5.82%6.03B | -1.20%5.91B | -5.09%5.87B | 0.18%5.8B | 10.72%5.7B |
| Receivable financing | 29.01%3.24B | 22.01%3.45B | -22.96%2.26B | -11.81%2.16B | 19.15%2.52B | -2.05%2.83B | 12.03%2.93B | -9.66%2.45B | -17.72%2.11B | -6.09%2.89B |
| Other current assets | 0.65%161.1M | 3.31%130.02M | 8.20%140.59M | -6.93%134.35M | 4.65%160.06M | 3.31%125.85M | -21.46%129.94M | -31.70%144.36M | -20.59%152.95M | -22.24%121.82M |
| Total current assets | 2.17%28.41B | 4.62%31B | 4.24%30.19B | 2.19%30.52B | 6.90%27.81B | -3.82%29.63B | -6.54%28.96B | -1.93%29.86B | -11.10%26.01B | 7.39%30.81B |
| Non Current assets | ||||||||||
| Other equity investment | -8.20%195.44M | -10.75%210.07M | 5.86%199.22M | 6.43%202.05M | 9.03%212.9M | 18.67%235.36M | -5.90%188.18M | -11.25%189.84M | 0.61%195.26M | 4.26%198.33M |
| Investment real estate | 13.29%101.14M | -9.19%85.27M | -6.91%85.74M | -5.20%88.89M | -2.25%89.28M | 7.97%93.9M | 3.82%92.11M | -2.13%93.77M | 10.52%91.34M | 3.56%86.97M |
| Long-term equity investment | 4.58%73.8M | -1.17%67.84M | -1.32%67.51M | 9.60%70.05M | 66.50%70.57M | 61.24%68.65M | 321.93%68.42M | 450.18%63.92M | 242.73%42.38M | 234.53%42.57M |
| Fixed assets | -4.43%1.35B | ---- | 25.32%1.38B | ---- | 24.47%1.42B | ---- | -6.53%1.1B | ---- | -6.20%1.14B | ---- |
| Constru in process | 47.38%349.69M | ---- | 147.37%342.99M | ---- | 82.41%237.27M | ---- | 75.55%138.65M | ---- | 62.14%130.08M | ---- |
| Intangible assets | -2.87%209.49M | -5.33%204.56M | -4.62%207.34M | -0.60%211.28M | -1.50%215.68M | -0.94%216.08M | -4.29%217.38M | -8.05%212.55M | -10.73%218.98M | -14.64%218.13M |
| Development expenditure | 173.40%50.41M | 103.00%34.19M | --29.85M | --21.85M | --18.44M | --16.84M | ---- | ---- | --0 | ---- |
| Goodwill | -12.36%63.24M | 0.00%72.17M | 0.00%72.17M | 0.00%72.17M | 0.00%72.17M | 0.00%72.17M | 0.00%72.17M | 0.00%72.17M | 0.00%72.17M | 0.00%72.17M |
| Long deferred expense | 7.22%47.85M | 7.88%51M | 3.66%48.1M | 2.73%44.48M | 2.97%44.63M | 8.33%47.27M | 3.43%46.4M | 1.36%43.3M | 17.48%43.34M | 35.16%43.64M |
| Deferred tax assets | 11.43%271.27M | 7.67%264.87M | 13.16%257.63M | 3.71%232.2M | 9.25%243.43M | 8.94%246M | 3.54%227.66M | 0.74%223.88M | -0.94%222.82M | 0.57%225.82M |
| Usufruct assets | 29.77%301.17M | 31.51%306.64M | 34.81%321.2M | 47.50%340.57M | -3.00%232.08M | -5.15%233.17M | -5.53%238.26M | -6.74%230.89M | 5.78%239.26M | -5.65%245.84M |
| Other non current assets | -84.85%2.04M | -99.11%2.7M | -98.70%3.91M | -95.59%13.49M | 216.99%13.46M | 5,959.91%301.65M | 9,356.76%301.96M | 18,180.41%305.61M | 107.11%4.25M | 140.13%4.98M |
| Total non current assets | 5.34%3.02B | 7.88%3.04B | 12.01%3.02B | 9.74%2.96B | 19.54%2.87B | 17.93%2.82B | 13.05%2.69B | 12.14%2.7B | 0.33%2.4B | -1.27%2.39B |
| Total assets | 2.47%31.43B | 4.90%34.05B | 4.90%33.21B | 2.81%33.48B | 7.97%30.67B | -2.25%32.45B | -5.14%31.66B | -0.89%32.56B | -10.24%28.41B | 6.71%33.2B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -40.31%1.22B | -7.22%4B | -15.94%3.84B | -0.32%4.48B | 15.92%2.04B | 16.54%4.31B | 6.21%4.57B | -1.76%4.49B | -2.27%1.76B | 8.60%3.7B |
| Notes payable and accounts payable | 9.06%11.1B | 2.81%10.13B | 5.98%10.17B | 6.30%10.06B | 4.97%10.18B | 3.51%9.86B | -1.50%9.59B | 1.53%9.46B | -4.32%9.69B | 6.40%9.52B |
| -Notes payable | 4.29%2.95B | 7.28%2.33B | 4.14%2.51B | 1.13%2.6B | 1.45%2.82B | -12.79%2.17B | -8.99%2.41B | 1.85%2.57B | -5.46%2.78B | 7.68%2.49B |
| -Accounts payable | 10.90%8.15B | 1.55%7.81B | 6.60%7.65B | 8.22%7.46B | 6.39%7.35B | 9.28%7.69B | 1.31%7.18B | 1.42%6.89B | -3.85%6.91B | 5.95%7.04B |
| Contract liabilities | 19.85%333.99M | 30.61%268.64M | 25.47%240.31M | 199.05%276.04M | 169.05%278.67M | 67.72%205.68M | 40.05%191.53M | -45.83%92.31M | -52.73%103.57M | 40.17%122.63M |
| Salaries payable | -11.54%212.82M | -20.21%133.75M | -17.88%131.24M | -8.37%158.76M | -2.11%240.58M | 2.75%167.62M | 6.27%159.82M | 4.98%173.26M | 4.41%245.76M | 0.81%163.14M |
| Taxs payable | 37.23%297.12M | -5.57%179M | 32.50%256.31M | -1.75%177.37M | 3.42%216.51M | -16.91%189.56M | 3.15%193.44M | -5.85%180.52M | -21.67%209.35M | 15.65%228.15M |
| Other payable (including interest and dividends) | -2.38%1.96B | -19.70%2.32B | 1.69%2.15B | 1.97%2.77B | -3.54%2B | 0.58%2.88B | -36.56%2.11B | -25.76%2.72B | -50.86%2.08B | -27.09%2.87B |
| -Dividend payable | 42.18%62.45M | ---- | 45.75%72.01M | ---- | 18.60%43.92M | ---- | -2.35%49.41M | ---- | -2.57%37.04M | 74.63%73.61M |
| -Other payable | -3.38%1.89B | ---- | 0.63%2.07B | ---- | -3.94%1.96B | ---- | -37.08%2.06B | ---- | -51.30%2.04B | ---- |
| Non current liabilities due within one year | -71.65%278.02M | -70.17%287.28M | -87.19%278.72M | -96.65%79.24M | -57.35%980.61M | -57.86%963.13M | 92.73%2.18B | 69.12%2.36B | 55.33%2.3B | -3.91%2.29B |
| Other current liabilities | 170.84%3.12B | 257.87%4.13B | 216.91%3.64B | -2.96%1.63B | -46.93%1.15B | -75.30%1.15B | -68.77%1.15B | -54.47%1.68B | -44.54%2.17B | 27.63%4.67B |
| Total current liabilities | 8.35%18.52B | 8.70%21.45B | 2.76%20.7B | -7.24%19.63B | -7.93%17.09B | -16.25%19.73B | -11.06%20.14B | -8.64%21.16B | -16.68%18.57B | 3.45%23.56B |
| Current liabilities | ||||||||||
| Long term loan | ---- | ---- | ---- | -55.79%200M | -81.83%200M | -41.10%648.48M | -71.83%648.48M | -80.33%452.38M | -31.25%1.1B | 56.95%1.1B |
| Bonds payable | -19.32%4.15B | 1.76%4.12B | 36.04%4.11B | 68.74%5.11B | 405.43%5.14B | 301.38%4.05B | 201.98%3.02B | --3.03B | 63.97%1.02B | 64.40%1.01B |
| Deferred tax liabilities | -1.71%58.04M | -16.50%62.69M | 7.69%58.44M | -39.56%32.43M | 6.57%59.05M | 33.81%75.08M | -4.79%54.26M | -9.09%53.67M | 2.17%55.41M | -23.18%56.11M |
| Long term deferred income | -6.06%260.79M | -5.25%266.96M | -5.78%269.49M | -6.93%273.56M | -6.55%277.62M | -3.16%281.75M | -3.04%286.03M | -1.99%293.93M | 1.33%297.06M | -3.00%290.93M |
| Lease liabilities | 65.32%192.07M | 54.63%190.86M | 84.64%215.07M | 93.87%226.03M | -2.39%116.18M | 1.43%123.43M | -10.15%116.48M | -13.27%116.59M | 15.29%119.02M | -1.04%121.69M |
| Total non current liabilities | -19.60%4.66B | -10.37%4.64B | 12.77%4.66B | 48.10%5.85B | 123.69%5.79B | 100.82%5.18B | 9.07%4.13B | 41.30%3.95B | -3.11%2.59B | 42.38%2.58B |
| Total liabilities | 1.27%23.18B | 4.73%26.09B | 4.47%25.35B | 1.46%25.47B | 8.18%22.89B | -4.70%24.91B | -8.18%24.27B | -3.26%25.11B | -15.23%21.16B | 6.32%26.14B |
| Shareholders equity | ||||||||||
| Paid-in capital | -0.03%1.31B | -0.03%1.31B | -0.03%1.31B | -0.07%1.31B | -0.07%1.31B | -0.07%1.31B | -0.08%1.31B | -0.01%1.31B | -0.01%1.31B | 0.11%1.31B |
| Other equity instruments | -25.30%6.68M | --6.68M | --6.68M | --8.94M | --8.94M | ---- | ---- | ---- | ---- | ---- |
| Capital reserve funds | -0.48%2.45B | -0.39%2.45B | -0.48%2.45B | 0.24%2.47B | 0.25%2.47B | 0.32%2.46B | 0.37%2.46B | 1.16%2.46B | 1.26%2.46B | 1.52%2.46B |
| Surplus reserve funds | 12.17%361.6M | 15.76%322.37M | 15.76%322.37M | 15.76%322.37M | 15.76%322.37M | 17.32%278.49M | 17.32%278.49M | 17.32%278.49M | 17.32%278.49M | 20.56%237.37M |
| Retained profit | 13.70%3.01B | 10.31%2.83B | 11.67%2.72B | 13.46%2.83B | 13.60%2.65B | 14.70%2.57B | 15.67%2.43B | 17.06%2.49B | 17.85%2.33B | 18.05%2.24B |
| Less:Treasury stock | 145.54%51.33M | 120.50%48.34M | 120.50%48.34M | -52.56%12.13M | -41.77%20.9M | -38.98%21.92M | -39.26%21.92M | -33.76%25.56M | -6.96%35.9M | -2.10%35.93M |
| Other composite income | -10.24%91.82M | -14.21%100.28M | 23.44%100.74M | 13.90%95.42M | 14.01%102.3M | 33.82%116.88M | -10.20%81.61M | -15.62%83.78M | 9.45%89.72M | 17.06%87.34M |
| Shareholders equity without minority interests | 5.07%7.19B | 3.90%6.97B | 4.82%6.86B | 6.34%7.02B | 6.26%6.84B | 6.68%6.71B | 6.23%6.54B | 6.97%6.6B | 7.26%6.44B | 7.41%6.29B |
| Minority interests | 12.42%1.07B | 17.99%984.06M | 17.94%994.41M | 15.34%987.88M | 15.88%949.87M | 7.67%834.03M | 7.87%843.15M | 16.79%856.49M | 17.94%819.73M | 15.11%774.62M |
| Total shareholder equity | 5.97%8.25B | 5.46%7.96B | 6.32%7.85B | 7.37%8.01B | 7.35%7.79B | 6.79%7.55B | 6.42%7.39B | 8.01%7.46B | 8.37%7.25B | 8.20%7.07B |
| Adjustment items of liabilities and equity | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- |
| Total liabilityies and equity | 2.47%31.43B | 4.90%34.05B | 4.90%33.21B | 2.81%33.48B | 7.97%30.67B | -2.25%32.45B | -5.14%31.66B | -0.89%32.56B | -10.24%28.41B | 6.71%33.2B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm